Diabetes By The Numbers: Type Zero Technologies.

Molly McElwee Malloy was my first interview here. She’s also my latest interview here.

A little over two months after the birth of Happy Medium, I saw Molly give a speech at a local JDRF meeting in Baltimore. At the time, she was clinical research coordinator at the Center for Diabetes Technology at the University of Virginia. She is also an RN and a Certified Diabetes Educator, and has been living with Type 1 Diabetes since 1998.

That was the first time I had seen anyone speak live about artificial pancreas development, how everything worked, and actually show me photos of the device they were testing. I was jazzed up about it, and the next day (and the day after that), I really bothered Molly for an interview. She said no, but said she would answer any questions I might have, so I could get all my facts straight.

In that instance as a new diabetes blogger with two months experience, and in the three years since, she has been kind, patient, and gracious when bombarded by my enthusiasm and my never-ending list of questions.

This month, Molly stepped into her latest role as Head of Patient Engagement at Type Zero Technologies, which is the commercial arm of AP research that was born many years ago at UVA’s Center for Diabetes Technology.

I am proud to say that she has finally gone on the record with me, for about 13 minutes, to talk about Type Zero and their InControl platform, including InControl Advice and InControl Cloud. She talks about those three products, the timing of upcoming clinical trials, and the plan for submitting these for approval to the U.S. Food and Drug Administration.

In reality, I wish we had more time, because this discussion could have easily gone two or three episodes. Instead, you’ll have to be satisfied with this little teaser, and then go to the Type Zero website to learn more.

Also, and this is important: Clinical trial participants are a very important piece of cutting-edge development like this. Please see below to find out more about volunteering to participate.
DBTN

Reference Material – Click below for more information on this topic

Find out more by going to the Type Zero Technologies website:
http://typezero.com

Follow Molly McElwee Malloy on Twitter:
@MollyMacT1D

Clinical trial participants are necessary and appreciated! Interested? Send an e-mail to:
artificialpancreas@virginia.edu
 

Post a comment or leave a trackback: Trackback URL.

Comments

  • Ally  On August 6, 2015 at 10:41 am

    First off, Stephen- you have such a radio voice! Loved the intro.

    This is probably the first podcast I’ve ever listened to from beginning to end. I always seem to discover great podcasts online, but then the location I am in does not have good internet access and my listening to the podcasts falls by the wayside. But I digress. Today I am working from home, and when I saw this on WordPress I knew it would be much better than the usual pop radio songs on repeat all morning.

    I’m so glad to have tuned in. I am aware of Molly on social media, but I had no idea as to the extent of her brave involvement in all of this technology development. It is truly exciting stuff, and she is a great person to have leading the charge. I liked the response about sharing the very particular knowledge and experience acquired over the years. What a great perspective. Also interesting was the ability to use the data to make appropriate treatment adjustments in various forms of treatment. When I think back to the days of pork-sourced insulin, where we are now and where we are going is so exciting.

    Thank you for this, Stephen and Molly.

    Liked by 1 person

  • Abbey Vandyk  On August 18, 2015 at 11:31 pm

    sounds very exciting and how does it it make suggestions on insulin and if tells i had to big where i had to much or smaller insulin for it to be high? Would it help me not have bottoming out spells or very high blood sugar after a big or huge meal like a pizza party or a special occasion? I’m praying i’ll get in the 6 month study next year and hopes works so well that the FDA won’t ask for more testing and call that they approved of it faster and review it quicker once type zero brings the data to the FDA and whens approval its not that fare off once we think about for their full automated system hang in their and stay strong about keep show them support for this cause the UVA worked their buts off it 2007. Keep have hope about it and keep the faith that will come to us.
    Abbey

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: